Dude every time there is good news the price drops. The conference call was brief but positive. Do you think that's normal? I believe these are mm scare tactics. Relatively there hasn't been that much dilution recently. There is absolutely no reason for this action period. IMO Cardio3 has about a $400 million market cap right now...a direct competitor. Mike Tomás warned against those that are tying to and I quote "derail Bioheart's success".
News 
Market Data 
Discover 
